secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001193125-25-282889
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics appoints Jeffrey Hessekiel as EVP, Chief Legal and Administrative Officer
--------------------------------------------------------------------------------

- Appointment effective Nov 14, 2025; Hessekiel previously EVP & General Counsel at Exelixis (2014-2025).
- Annual base salary of $660,000 and target bonus of 50% of base salary.
- Signing bonus of $400,000 payable 50% on first payroll cycle and 50% after one year.
- Initial RSU award of $5,800,000 grant-date value vests 40/40/20 over three years.
- Eligible for company benefit plans, 2004 Equity Incentive Plan, and Executive Severance Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000119312525282889/0001193125-25-282889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000119312525282889/cytk-20251113.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-282889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer